Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR, Stain AM, Chan A, McLimont M, Chait S, Wu J, Poon MC, Card R, Israels SJ, Laferriere N, Klaassen RJ, Rivard GE, Cloutier S, Hawes S, Feldman B, Blanchette V.
Langley AR, et al. Among authors: cloutier s.
Haemophilia. 2015 Jul;21(4):469-76. doi: 10.1111/hae.12713.
Haemophilia. 2015.
PMID: 26104147
Clinical Trial.